BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34493178)

  • 1. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2019.
    Peck H; Moselen J; Brown SK; Triantafilou M; Lau H; Grau M; Barr IG; Leung VK
    Commun Dis Intell (2018); 2021 Aug; 45():. PubMed ID: 34493178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021.
    O'Neill G; Aziz A; Kuba M; Brown SK; Lau H; Soppe S; Baz M; Peck H; Deng YM; Subbarao K; Barr IG
    Commun Dis Intell (2018); 2022 Sep; 46():. PubMed ID: 36154657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2022.
    Diefenbach-Elstob TR; Chanthalavanh P; Bobbitt ME; Brown SK; Rynehart C; Spirason N; Peck H; Deng YM; Dapat C; Subbarao K; Barr IG
    Commun Dis Intell (2018); 2023 Jul; 47():. PubMed ID: 37817300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018.
    Price OH; Spirason N; Rynehart C; Brown SK; Todd A; Peck H; Patel M; Soppe S; Barr IG; Chow MK
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2015.
    Leung VK; Spirason N; Lau H; Buettner I; Leang SK; Chow MK
    Commun Dis Intell Q Rep; 2017 Jun; 41(2):E150-E160. PubMed ID: 28899310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2017.
    Roe M; Kaye M; Iannello P; Lau H; Buettner I; Tolosa MX; Zakis T; Leung VK; Chow MK
    Commun Dis Intell (2018); 2019 Jun; 43():. PubMed ID: 31203585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2014.
    Sullivan SG; Chow MK; Barr IG; Kelso A
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E602-11. PubMed ID: 26779736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2016.
    Leung VK; Deng YM; Kaye M; Buettner I; Lau H; Leang SK; Gillespie L; Chow MK
    Commun Dis Intell (2018); 2019 Feb; 43():. PubMed ID: 30739429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Melidou A; Hungnes O; Pereyaslov D; Adlhoch C; Segaloff H; Robesyn E; Penttinen P; Olsen SJ;
    Vaccine; 2020 Jul; 38(35):5707-5717. PubMed ID: 32624252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.
    Klimov AI; Garten R; Russell C; Barr IG; Besselaar TG; Daniels R; Engelhardt OG; Grohmann G; Itamura S; Kelso A; McCauley J; Odagiri T; Smith D; Tashiro M; Xu X; Webby R; Wang D; Ye Z; Yuelong S; Zhang W; Cox N;
    Vaccine; 2012 Oct; 30(45):6461-71. PubMed ID: 22917957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.
    Barr IG; Russell C; Besselaar TG; Cox NJ; Daniels RS; Donis R; Engelhardt OG; Grohmann G; Itamura S; Kelso A; McCauley J; Odagiri T; Schultz-Cherry S; Shu Y; Smith D; Tashiro M; Wang D; Webby R; Xu X; Ye Z; Zhang W;
    Vaccine; 2014 Aug; 32(37):4713-25. PubMed ID: 24582632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
    Altaş AB; Bayrakdar F; Korukluoğlu G
    Mikrobiyol Bul; 2016 Jul; 50(3):401-17. PubMed ID: 27525396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
    Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
    Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    Miron VD; Bănică L; Săndulescu O; Paraschiv S; Surleac M; Florea D; Vlaicu O; Milu P; Streinu-Cercel A; Bilașco A; Oțelea D; Pițigoi D; Streinu-Cercel A; Drăgănescu AC
    PLoS One; 2021; 16(11):e0258798. PubMed ID: 34767579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.
    Fang Q; Gao Y; Chen M; Guo X; Yang X; Yang X; Wei L
    Infect Genet Evol; 2014 Aug; 26():228-40. PubMed ID: 24911284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria.
    Korsun N; Angelova S; Trifonova I; Tzotcheva I; Mileva S; Voleva S; Georgieva I; Perenovska P
    J Med Microbiol; 2018 Feb; 67(2):228-239. PubMed ID: 29297852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.
    Korsun N; Daniels R; Angelova S; Ermetal B; Grigorova I; Voleva S; Trifonova I; Kurchatova A; McCauley J
    J Med Microbiol; 2020 Jul; 69(7):986-998. PubMed ID: 32459617
    [No Abstract]   [Full Text] [Related]  

  • 20. The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009.
    Vuong CD; Hoang PM; Nguyen HL; Nguyen HT; Nguyen TC; Le TT; Dennis DT; Kapella BK; Kile JC; Le MQ
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1151-7. PubMed ID: 23137010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.